• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内质网靶向序列增强基于CTL表位的DNA疫苗诱导的HBV特异性细胞毒性T淋巴细胞。

Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.

作者信息

Xu Wei, Chu Yiwei, Zhang Ruihua, Xu Huanbin, Wang Ying, Xiong Sidong

机构信息

Department of Immunology, Shanghai Medical College of Fudan University, Shanghai, PR China.

出版信息

Virology. 2005 Apr 10;334(2):255-63. doi: 10.1016/j.virol.2005.01.040.

DOI:10.1016/j.virol.2005.01.040
PMID:15780875
Abstract

CD8(+) T cells play a critical role in protective immunity against Hepatitis B Virus (HBV). Epitope-based DNA vaccines expressing HBV-dominant CTL epitopes can be used as candidate vaccines capable of inducing cytotoxic T Lymphocytes (CTL) responses. A plasmid DNA encoding a CTL epitope of HBV core antigen, HBc(18-27), was constructed. Intramuscular immunization of C57BL/6 mice with this DNA vaccine resulted in successful induction of HBV-specific CTL responses. In order to promote transportation of the peptide into endoplasmic reticulum (ER) to bind to MHC class I molecules for optimal class I antigen presentation, an ER targeting sequence (ERTS) was fused with the C(18-27) encoding gene. ERTS fusion significantly enhanced specific CD8(+) T cell responses in terms of CTL cytolysis as well as IFN-gamma secretion. This enhancement was correlated with promoted epitope presentation on target cell surface. We report here an enhanced immunogenicity of an epitope-based DNA vaccine using an ER targeting signal sequence, which has significant implications for future design of therapeutic HBV vaccine.

摘要

CD8(+) T细胞在抗乙型肝炎病毒(HBV)的保护性免疫中发挥关键作用。表达HBV优势CTL表位的基于表位的DNA疫苗可作为能够诱导细胞毒性T淋巴细胞(CTL)反应的候选疫苗。构建了一种编码HBV核心抗原CTL表位HBc(18 - 27)的质粒DNA。用这种DNA疫苗对C57BL/6小鼠进行肌肉内免疫成功诱导了HBV特异性CTL反应。为了促进肽转运到内质网(ER)以与MHC I类分子结合从而实现最佳的I类抗原呈递,将内质网靶向序列(ERTS)与编码C(18 - 27)的基因融合。ERTS融合在CTL细胞溶解以及IFN-γ分泌方面显著增强了特异性CD8(+) T细胞反应。这种增强与靶细胞表面表位呈递的促进相关。我们在此报告使用内质网靶向信号序列增强了基于表位的DNA疫苗的免疫原性,这对治疗性HBV疫苗的未来设计具有重要意义。

相似文献

1
Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.内质网靶向序列增强基于CTL表位的DNA疫苗诱导的HBV特异性细胞毒性T淋巴细胞。
Virology. 2005 Apr 10;334(2):255-63. doi: 10.1016/j.virol.2005.01.040.
2
A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice.一种基于T细胞表位的新型乙肝病毒DNA疫苗及其在乙肝病毒转基因小鼠中的潜在治疗效果。
Int Immunol. 2005 Oct;17(10):1293-302. doi: 10.1093/intimm/dxh305. Epub 2005 Aug 19.
3
Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.从多特异性DNA疫苗中去除免疫显性表位可诱导具有显著抗病毒潜力的CD8 T细胞。
J Immunol. 2009 Jul 1;183(1):370-80. doi: 10.4049/jimmunol.0900505.
4
Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.利用MHC I类转基因小鼠开发编码多个HLA限制性CTL表位的小基因DNA疫苗。
J Immunol. 1999 Apr 1;162(7):3915-25.
5
A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.结核分枝杆菌HSP70基因的截短C末端片段增强了乙肝病毒DNA疫苗的效力。
Vaccine. 2006 Apr 12;24(16):3321-31. doi: 10.1016/j.vaccine.2006.01.012. Epub 2006 Jan 19.
6
DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.DNA免疫可在H-2b小鼠中诱导针对乙肝核心抗原的抗体和细胞毒性T细胞反应。
J Immunol. 1996 May 15;156(10):3687-95.
7
Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.启动针对外源性乙肝表面抗原的MHC-I限制性细胞毒性T淋巴细胞反应依赖于CD4 + T细胞。
J Immunol. 1999 Aug 15;163(4):1880-7.
8
Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.接种编码乙型肝炎表面抗原与 CTLA-4 胞外域融合的融合 DNA 疫苗可增强小鼠乙型肝炎病毒特异性免疫应答:其作为治疗性疫苗的潜在用途。
Clin Immunol. 2010 Nov;137(2):190-8. doi: 10.1016/j.clim.2010.07.002. Epub 2010 Aug 7.
9
Single B or T-cell epitope-based DNA vaccine using modified vector induces specific immune response against hepadnavirus.使用修饰载体的基于单个B或T细胞表位的DNA疫苗可诱导针对嗜肝DNA病毒的特异性免疫反应。
Immunol Lett. 2005 Jul 15;99(2):186-92. doi: 10.1016/j.imlet.2005.02.014. Epub 2005 Mar 25.
10
[Inducement of cytotoxic T cell responses in mice by constructing a multi-CTL epitope-based DNA vaccine].[通过构建基于多细胞毒性T淋巴细胞表位的DNA疫苗诱导小鼠细胞毒性T细胞应答]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Jul;22(4):430-2.

引用本文的文献

1
Endoplasmic reticulum-targeting sequence enhanced the cellular immunity of a tumor-associated antigen L6-based DNA vaccine.内质网靶向序列增强了基于肿瘤相关抗原L6的DNA疫苗的细胞免疫。
Am J Cancer Res. 2019 Sep 1;9(9):2028-2036. eCollection 2019.
2
Design, Synthesis, and Bioactive Screen In Vitro of Cyclohexyl ()-4-(Hydroxyimino)-4-Phenylbutanoates and Their Ethers for Anti-Hepatitis B Virus Agents.设计、合成及体外筛选环己基()-4-(羟亚氨基)-4-苯基丁酸酯及其醚类化合物抗乙型肝炎病毒活性。
Molecules. 2019 May 30;24(11):2063. doi: 10.3390/molecules24112063.
3
Discovery of Oxime Ethers as Hepatitis B Virus (HBV) Inhibitors by Docking, Screening and In Vitro Investigation.
通过对接、筛选和体外研究发现肟醚类化合物为乙型肝炎病毒(HBV)抑制剂。
Molecules. 2018 Mar 12;23(3):637. doi: 10.3390/molecules23030637.
4
A fusion DNA vaccine encoding middle version of HBV envelope protein fused to interleukin-21 did not enhance HBV-specific immune response in mice.一种编码与白细胞介素-21融合的乙肝病毒包膜蛋白中间版本的融合DNA疫苗,并未增强小鼠体内乙肝病毒特异性免疫反应。
Viral Immunol. 2014 Nov;27(9):430-7. doi: 10.1089/vim.2014.0051. Epub 2014 Sep 11.
5
DNA vaccination strategies for anti-tumour effective gene therapy protocols.用于抗肿瘤有效基因治疗方案的 DNA 疫苗接种策略。
Cancer Immunol Immunother. 2010 Oct;59(10):1583-91. doi: 10.1007/s00262-010-0853-x.
6
Comparative analysis of antigen-targeting sequences used in DNA vaccines.DNA 疫苗中使用的抗原靶向序列的比较分析。
Mol Biotechnol. 2010 Mar;44(3):204-12. doi: 10.1007/s12033-009-9229-x.
7
Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c mice.携带免疫增强序列的丙型肝炎病毒多表位疫苗候选物的构建及其在BALB/c小鼠中的免疫原性初步评估。
Virus Genes. 2010 Feb;40(1):44-52. doi: 10.1007/s11262-009-0417-3. Epub 2009 Oct 31.
8
Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.质粒DNA疫苗载体设计:对效力、安全性及上游生产的影响
Biotechnol Adv. 2009 Jul-Aug;27(4):353-70. doi: 10.1016/j.biotechadv.2009.02.003. Epub 2009 Feb 20.
9
A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro.一种嵌合多表位DNA疫苗引发了针对严重急性呼吸综合征相关冠状病毒的特异性抗体反应,该反应在体外减弱了SARS-CoV的毒力。
Immunol Lett. 2008 Aug 15;119(1-2):71-7. doi: 10.1016/j.imlet.2008.04.005. Epub 2008 May 19.
10
Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen.白细胞介素-15质粒共免疫增强了由编码乙肝病毒核心抗原的DNA诱导的CD8 T细胞的寿命。
World J Gastroenterol. 2006 Aug 7;12(29):4727-35. doi: 10.3748/wjg.v12.i29.4727.